Anne DHombres
Overview
Explore the profile of Anne DHombres including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seyve A, Dehais C, Chinot O, Djelad A, Cohen-Moyal E, Bronnimann C, et al.
Neuro Oncol
. 2022 Aug;
25(3):495-507.
PMID: 35953421
Background: Incidence and characteristics of pseudoprogression in isocitrate dehydrogenase-mutant high-grade gliomas (IDHmt HGG) remain to be specifically described. Methods: We analyzed pseudoprogression characteristics and explored the possibility of pseudoprogression misdiagnosis...
2.
Mesny E, Barritault M, Izquierdo C, Poncet D, DHombres A, Guyotat J, et al.
J Neurooncol
. 2022 Apr;
157(3):511-521.
PMID: 35364762
Background: Molecular glioblastomas (i.e. without the histological but with the molecular characteristics of IDH-wild-type glioblastoma) frequently lack contrast enhancement, which can wrongly lead to suspect a lower-grade glioma. Herein, we...
3.
Barritault M, Picart T, Poncet D, Fenouil T, DHombres A, Gabut M, et al.
Neurosurgery
. 2020 Feb;
87(4):E513-E519.
PMID: 32107549
Background: Biopsies in patients with a suspected glioma are occasionally nondiagnostic. Objective: To explore the utility of molecular testing in this setting by determining whether IDH1 and TERT promoter (pTERT)...
4.
Starnoni D, Berthiller J, Idriceanu T, Meyronet D, DHombres A, Ducray F, et al.
Neurosurg Focus
. 2018 Jun;
44(6):E17.
PMID: 29852767
OBJECTIVE Although multimodal treatment for glioblastoma (GBM) has resulted in longer survival, uncertainties exist regarding health-related quality of life and functional performance. Employment represents a useful functional end point and...
5.
Granzotto A, Benadjaoud M, Vogin G, Devic C, Ferlazzo M, Bodgi L, et al.
Int J Radiat Oncol Biol Phys
. 2016 Feb;
94(3):450-60.
PMID: 26867874
Purpose: Whereas post-radiation therapy overreactions (OR) represent a clinical and societal issue, there is still no consensual radiobiological endpoint to predict clinical radiosensitivity. Since 2003, skin biopsy specimens have been...
6.
Laffay L, Depaepe L, DHombres A, Balme B, Thomas L, De Bari B
Tumori
. 2012 Jun;
98(2):46e-49e.
PMID: 22678003
Background: Trichoblastic carcinoma (or malignant trichoblastoma) is a rare malignant cancer of adnexal structures with morphological features that in some cases are reminiscent of a trichoblastoma. Trichoblastic carcinoma is underdiagnosed...
7.
Noel G, Huchet A, Feuvret L, Maire J, Verrelle P, Le Rhun E, et al.
J Neurooncol
. 2012 Jun;
109(1):167-75.
PMID: 22660920
Purpose of this study was to determine the effect of waiting time for radiotherapy on overall survival of patients with glioblastoma treated in the EORTC-NCIC trial at 18 centers in...
8.
Abouaf L, Girard N, Lefort T, DHombres A, Tilikete C, Vighetto A, et al.
Int J Radiat Oncol Biol Phys
. 2011 Jun;
82(3):1268-77.
PMID: 21640493
Purpose: Radiotherapy has shown its efficacy in controlling optic nerve sheath meningiomas (ONSM) tumor growth while allowing visual acuity to improve or stabilize. However, radiation-induced toxicity may ultimately jeopardize the...
9.
Pommier P, Dussart S, Girinsky T, Chabaud S, Lagrange J, Nguyen T, et al.
Int J Radiat Oncol Biol Phys
. 2010 May;
79(3):823-8.
PMID: 20452732
Purpose: To quantify the impact of preradiotherapy 18F-fluoro-2-deoxyglucose positron-emission tomography (FDG-PET) on treatment strategy and radiotherapy planning for patients with Stage I/II Hodgkin disease included in a large prospective multicenter...
10.
Petit T, Velten M, DHombres A, Marchal C, Montbarbon X, Mornex F, et al.
Gynecol Oncol
. 2006 Sep;
104(1):104-8.
PMID: 16987544
Objective: Attempts to increase survival in stage III ovarian cancer patients with minimal residual disease at second-look laparotomy have included consolidation radiotherapy. We present long-term survival of 106 consecutive patients...